7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      operating activities:
    		                   
      net income
    		10,202,000 8,758,000 2,361,000 23,400,000 18,201,000 7,474,000 7,156,000 33,105,000 13,347,000 12,839,000 12,175,000 18,068,000 10,331,000 10,290,000 4,579,000 28,308,000 7,924,000 -12,568,000 5,644,000 
      adjustments to reconcile net income to net cash from operating activities
    		                   
      bad debt expense
    		398,000 516,000 983,000 1,447,000 2,093,000 546,000 907,000 3,174,000 3,195,000 2,421,000 1,285,000 1,404,000 1,632,000 918,000 1,079,000     
      depreciation and amortization expense
    		15,191,000 14,697,000 12,387,000 11,800,000 11,483,000 11,004,000 10,928,000 11,520,000 10,706,000 9,676,000 8,983,000 8,882,000 8,089,000 8,317,000 9,040,000 8,296,000 7,493,000 7,439,000 7,057,000 
      amortization of debt issuance costs
    		109,000 108,000 109,000 108,000 187,000 73,000 74,000 73,000 74,000 73,000 74,000 73,000 74,000 73,000 74,000 73,000 74,000 73,000 74,000 
      non-cash lease expense
    		1,998,000 2,031,000 1,874,000 1,835,000 2,138,000 1,622,000 1,569,000 1,828,000 1,606,000 1,635,000 1,658,000 1,805,000 1,652,000 1,880,000 2,002,000     
      deferred taxes
    		16,757,000 3,665,000 -3,367,000 -4,400,000 -5,723,000 -7,567,000 -3,963,000 -5,325,000 -3,082,000 -11,257,000 -5,382,000 -13,607,000 -2,000,000 -1,958,000 -2,016,000 -3,294,000 -1,397,000 -1,847,000 -1,328,000 
      stock-based compensation expense
    		27,379,000 27,007,000 24,342,000 22,752,000 22,950,000 24,715,000 20,241,000 16,473,000 15,791,000 15,167,000 11,813,000 11,083,000 10,971,000 9,259,000 10,994,000  4,848,000 4,714,000 2,538,000 
      interest income
    		66,000    -70,000          -14,000     
      loss on disposal of fixed assets
    		12,000 0 89,000     0 0   0 8,000 874,000 471,000     
      other
    		1,190,000 285,000 -704,000 1,978,000 -222,000 905,000 677,000 -382,000 665,000 211,000 -2,000 -231,000 620,000 -152,000 -150,000 72,000 599,000 130,000 -68,000 
      changes in operating assets and liabilities, net of effects of business combinations
    		                   
      trade receivables
    		-29,355,000 26,185,000 14,766,000 -37,035,000 -6,064,000 6,771,000 9,626,000 -17,904,000 -13,573,000 -4,162,000 -8,052,000 -25,923,000 -1,900,000 -9,718,000 -12,224,000 -22,694,000 -7,828,000 715,000 7,803,000 
      prepaid expenses and other assets
    		-4,062,000 -22,232,000 -10,530,000 1,240,000 4,616,000 -11,990,000 -5,218,000 3,779,000 1,798,000 -4,294,000 -6,874,000 11,204,000 -1,161,000 1,383,000 -2,332,000     
      trade payables
    		419,000 301,000 337,000 -1,684,000 2,693,000 -2,131,000 55,000 3,001,000 349,000 -1,574,000 3,700,000 -568,000 1,190,000 2,260,000 2,000 -474,000    
      accrued expenses and other liabilities
    		10,877,000 -11,664,000 -5,283,000 15,029,000 2,343,000 5,307,000 -10,342,000 4,014,000 4,495,000 -10,027,000 2,048,000 24,211,000 2,371,000 3,776,000 -13,754,000     
      net cash from operating activities
    		51,181,000 49,613,000 37,663,000 37,384,000 54,625,000 35,881,000 31,774,000 52,055,000 35,522,000 10,738,000 21,426,000 36,501,000 31,812,000 28,798,000 -2,249,000 24,315,000 16,206,000 22,764,000 19,464,000 
      capex
    		-12,139,000 -9,527,000 -6,286,000 -7,357,000 -6,234,000 -7,165,000 -6,393,000 -4,700,000 -4,638,000 -3,572,000 -4,099,000 -12,262,000 -14,113,000 -8,847,000 -4,759,000 -3,898,000 -1,986,000 -1,598,000 -1,915,000 
      free cash flows
    		39,042,000 40,086,000 31,377,000 30,027,000 48,391,000 28,716,000 25,381,000 47,355,000 30,884,000 7,166,000 17,327,000 24,239,000 17,699,000 19,951,000 -7,008,000 20,417,000 14,220,000 21,166,000 17,549,000 
      investing activities:
    		                   
      purchase of property, plant and equipment
    		-12,139,000 -9,527,000 -6,286,000 -7,357,000 -6,234,000 -7,165,000 -6,393,000 -4,700,000 -4,638,000 -3,572,000 -4,099,000 -12,262,000 -14,113,000 -8,847,000 -4,759,000 -3,898,000 -1,986,000 -1,598,000 -1,915,000 
      acquisition of businesses, net of cash acquired
    		0 0 -82,578,000     0            
      purchase of short-term investments
    		   -17,692,000 0 -49,726,000 -32,211,000             
      proceeds from maturity of short-term investments
    		5,069,000   49,727,000                
      other investing activities
    		0 0 -1,000,000                 
      net cash from investing activities
    		-7,070,000 3,157,000 -89,864,000 24,678,000 25,976,000 -56,891,000 -38,604,000             
      financing activities:
    		                   
      proceeds from common stock issued upon exercise of stock options
    		260,000 148,000 222,000 426,000 324,000 870,000 1,695,000 2,856,000 2,053,000 3,991,000 1,766,000 896,000 2,391,000 838,000 1,678,000 6,926,000 2,067,000 2,909,000 538,000 
      proceeds from common stock issued under employee purchase plan
    		0   1,617,000 0   1,585,000 0   966,000 0       
      finance lease payments
    		-1,565,000 -854,000 -525,000 -535,000 -378,000 -747,000 -815,000 -709,000 -577,000 -515,000 -513,000 -638,000 -379,000 -427,000 -480,000     
      shares repurchased under the repurchase program and new repurchase program
    		-50,065,000 0 -82,240,000                 
      payment of excise tax on shares repurchased
    		0                   
      shares repurchased for settlement of employee tax withholdings
    		-3,391,000 -494,000 -3,210,000 -2,734,000 -636,000 -660,000 -1,792,000 -888,000 -945,000 -1,966,000 -787,000 -561,000 -492,000 -8,133,000 -1,058,000 0    
      net cash from financing activities
    		-54,761,000 -291,000 -85,753,000 -79,173,000 -25,715,000 -23,650,000 -912,000 2,844,000 531,000 2,648,000 466,000 663,000 1,520,000   6,362,000 -242,000   
      effect of exchange rate changes on cash and cash equivalents and restricted cash
    		-438,000 3,021,000 1,526,000 -2,039,000 1,000,000 -473,000 -377,000 727,000 -404,000 -116,000 131,000 231,000 -277,000 -869,000 131,000 -27,000 -186,000 222,000 -209,000 
      net increase in cash, cash equivalents, and restricted cash
    		   -19,150,000 55,886,000 -45,133,000 -8,119,000 50,926,000 -36,229,000 9,698,000 17,924,000 25,133,000 18,942,000 12,128,000 -9,990,000 -98,142,000 -10,531,000 280,541,000 16,462,000 
      cash, cash equivalents, and restricted cash - beginning of period
    		0 0 293,741,000  0 0 310,257,000  0 0 267,938,000  0 0 221,725,000  0 0 33,395,000 
      cash, cash equivalents, and restricted cash - end of period
    		-11,088,000 55,500,000 157,313,000  55,886,000 -45,133,000 302,138,000  -36,229,000 9,698,000 285,862,000  18,942,000 12,128,000 211,735,000  -10,531,000 280,541,000 49,857,000 
      ​
    		                   
      cash and cash equivalents
    		-11,055,000 55,424,000 156,360,000 -19,090,000 55,844,000 -45,951,000 302,017,000 50,919,000 -36,225,000 9,699,000 285,738,000 25,126,000 18,949,000 12,138,000 211,600,000 -98,234,000 -10,530,000 280,540,000 49,815,000 
      restricted cash - current
    		 3,000 34,000 -95,000                
      restricted cash - non-current
    		4,000 73,000 919,000 35,000                
      total cash and cash equivalents and restricted cash
    		-11,088,000 55,500,000 157,313,000 -19,150,000 55,886,000 -45,133,000 302,138,000 50,926,000 -36,229,000 9,698,000 285,862,000 25,133,000 18,942,000 12,128,000 211,735,000 -98,142,000 -10,531,000 280,541,000 49,857,000 
      supplemental cash flow information:
    		                   
      cash paid for taxes
    		1,955,000 53,396,000 2,366,000 5,788,000 6,650,000 28,167,000 1,324,000 8,145,000 11,454,000 39,576,000 1,708,000 2,141,000 9,049,000 213,000 948,000 2,112,000 2,281,000 2,260,000 1,045,000 
      cash paid for interest
    		378,000 459,000 41,000 49,000 80,000 276,000 74,000 287,000 38,000 123,000 266,000 35,000 237,000 38,000 244,000 194,000 55,000 378,000 147,000 
      non-cash investing and financing activities:
    		                   
      right-of-use assets obtained in exchange for new operating lease liabilities, net of impairments and tenant improvement allowances
    		2,971,000 353,000 1,815,000 -462,000 5,342,000 3,004,000 6,207,000 530,000 756,000 -154,000 1,415,000         
      acquisition of equipment under finance lease
    		0 0 13,805,000     0 0           
      capital assets financed by accounts payable and accrued expenses
    		-214,000 151,000 98,000 -76,000 64,000 -27,000 45,000   102,000 378,000         
      stock-based compensation included in capitalized software development costs
    		1,407,000 1,039,000 744,000 555,000 521,000 593,000 471,000 395,000 297,000 232,000 179,000 113,000 109,000       
      accrued excise tax on net share repurchases
    		396,000 -157,000 732,000                 
      net decrease in cash, cash equivalents, and restricted cash
    		 55,500,000 -136,428,000                 
      interest expense
    		  299,000    64,000 -108,000 151,000   100,000 -65,000   -27,000 121,000 -57,000 66,000 
      impairment of long-lived assets
    		           0 0       
      change in fair value of contingent consideration
    		               0 0   
      proceeds from revolving credit facility
    		       0 0 0 50,000,000         
      payments to revolving credit facility
    		       0 0 0 -50,000,000         
      payment of contingent consideration related to zentrick acquisition
    		           0 0 0 -3,247,000     
      payments related to offering costs
    		           0 0 0 -6,000 -272,000 -89,000 -20,527,000 -1,181,000 
      shares repurchased under the repurchase program
    		   -77,947,000 -25,025,000               
      cash, cash equivalents, and restricted cash—beginning of period
    		                   
      cash, cash equivalents, and restricted cash—end of period
    		                   
      non‑cash investing and financing transactions:
    		                   
      common stock issued in connection with acquisition
    		       0            
      liabilities for contingent consideration
    		       0            
      changes in operating assets and liabilities
    		                   
      restricted cash
    		     818,000 121,000 7,000 -4,000 -1,000 124,000 7,000 -7,000 -10,000 135,000 92,000 -1,000 1,000 42,000 
      offering costs
    		               277,000 -4,000 18,728,000 3,073,000 
      payments of long-term debt
    		               0 0   
      deferred payment related to zentrick acquisition
    		               0 0   
      proceeds from issuance of common stock upon initial public offering
    		               0 0   
      proceeds from issuance of common stock in connection to concurrent private placement
    		                   
      treasury stock reissued upon the conversion of series a preferred stock for common stock
    		                   
      offering costs included in accounts payable and accrued expense
    		                 -1,800,000 1,889,000 
      net cash (used in) investing activities
    		        -71,878,000 -3,572,000 -4,099,000  -14,113,000 -8,847,000 -4,759,000  -26,309,000 -1,598,000 -1,915,000 
      loss on extinguishment of debt
    		                   
      accretion of acquisition liabilities
    		                   
      proceeds from long-term debt
    		                   
      deferred payment related to leiki acquisition
    		                   
      repurchase of vested options
    		                   
      proceeds from series a preferred stock issuance, net of issuance costs
    		                   
      payments to shareholders for preferred stock series a
    		                   
      payments related to debt issuance costs
    		                   
      exchange of common stock for preferred stock
    		                   
      capital assets financed by accounts payable
    		           -5,293,000    -5,000    
      changes in operating assets and liabilities net of effect of business combinations
    		                   
      acquisition of business, net of cash acquired
    		                   
      right-of-use assets obtained in exchange for new operating lease liabilities, net of impairments
    		            495,000       
      conversion of series a preferred stock to common stock
    		                   
      net cash (used in) financing activities
    		              -3,113,000    -878,000 
      right-of-use assets obtained in exchange for new operating lease liabilities
    		              79,563,000     
      bad debt (recovery) expense
    		               475,000   -390,000 
      noncash stock-based compensation expense
    		                   
      prepaid expenses and other current assets
    		               -11,636,000 4,874,000 -2,038,000 1,754,000 
      other non-current assets
    		               -359,000 137,000 -287,000 -12,000 
      accrued expenses
    		               14,630,000 -805,000 6,590,000 -6,469,000 
      other current liabilities
    		               994,000 1,920,000 -275,000 1,102,000 
      other non-current liabilities
    		               -113,000 -249,000 -264,000 -856,000 
      deferred payment related to acquisition of assets
    		                   
      capital lease payments
    		               -696,000 -418,000 -569,000 -235,000 
      deferred payment obligation issued as consideration
    		                   
      contingent consideration issued
    		                   
      acquisition of equipment under capital lease
    		               0 0 0 1,518,000 
      computer equipment
    		                   
      office furniture and equipment
    		                   
      leasehold improvements
    		                   
      proceeds from issuance of common stock in connection with concurrent private placement
    		                0   
      conversion of series a preferred stock to common stock in connection with the initial public offering
    		                0   
      treasury stock reissued upon the conversion of series a preferred stock to common stock
    		                0   
      trade payables and other liabilities
    		                 1,065,000 -524,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.